Compounds > 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide
Page last updated: 2024-09-03

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and didanosine

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with didanosine in 1 studies

Compound Research Comparison

Studies
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)		Trials
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)		Recent Studies (post-2010)
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)		Studies
(didanosine)		Trials
(didanosine)		Recent Studies (post-2010) (didanosine)
21022,054459166

Protein Interaction Comparison

ProteinTaxonomy5-ethynyl-1-ribofuranosylimidazole-4-carboxamide (IC50)didanosine (IC50)
Reverse transcriptase/RNaseH Human immunodeficiency virus 16.26

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzarini, J; De Clercq, E; Lee, CK; Schols, D1

Other Studies

1 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and didanosine

ArticleYear
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymph
    Biochemical and biophysical research communications, 1991, Jul-31, Volume: 178, Issue:2

    Topics: Antiviral Agents; Cells, Cultured; Didanosine; Drug Synergism; Guanosine Diphosphate; Guanosine Monophosphate; Guanosine Triphosphate; HIV-1; Humans; Inosine Monophosphate; Kinetics; Lymphocytes; Ribavirin; Ribonucleosides

1991